Indication | Care area | Age | Weight (kg) | Dose |
---|---|---|---|---|
Meningitis | Bone marrow transplant | ≤29 days | < 8 | 100 mg/kg/dose IV q8h |
 |  |  | ≥8 | 100 mg/kg/dose IV q8 h up to a max single dose of 1 g |
 | NICU, transitional care | ≤7 days | any | 100 mg/kg/dose IV/IM q8 h (equivalent to 300 mg/kg/day) |
 |  | ≥8 | any | 75 mg/kg/dose IV q6 h (approx. 300 mg/kg/day) |
 | PICU, cardiac ICU | ≤29 days | ≥8 | 100 mg/kg/dose IV q8 h up to a max single dose of 1 g |
 |  |  | Any | 100 mg/kg/dose IV q8h |
Meningitis or osteomyelitis | General care | ≥14 yrs | < 27 | 75 mg/kg/dose IV q6h |
 |  |  | ≥27 | 2 g IV q6h |
 | Non-pediatric location | ≤7 days | ≥9 | 100 mg/kg/dose IV q8 h up to a max single dose of 1 g |
 |  |  | < 9 | 100 mg/kg/dose IV q8h |
 |  | 8 days-14 yrs | < 27 | 75 mg/kg/dose IV q6h |
 |  |  | ≥27 | 2 g IV q6h |
 |  | 14-18 yrs | ≥27 & <45 | 2 g IV q6h |
 |  |  | < 27 | 75 mg/kg/dose IV q6h |
Pediatric liver transplant - post-op | Any location - dosing region scenarios defined by order set use | ≥0 days | < 20 | 50 mg/kg q6 h × 4 doses |
 |  |  | ≥20 | 1 g q6 h × 4 doses |
Pediatric liver transplant - pre-op | Any location - dosing region scenarios defined by order set use | ≥0 days | < 20 | 50 mg/kg ONCALLPRN* to OR |
 |  |  | ≥20 | 1 g ONCALLPRN* to OR |